SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the outstanding common shares, today sent a letter to its fellow Sinovac shareholders exposing the current Sinovac Board’s failure to act in the interest of all shareholders resulting in failure to pay shareholders dividends and to resume trading of the shares after a six-year halt. This is a stark contrast to the ten highly quali...

Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, and Westinghouse Electric Company LLC, a leading supplier of nuclear plant instrumentation and control systems, have announced a strategic partnership to provide digital Ex-core Nuclear Instrumentation Systems (NIS) based on the high-performing Mirion proTK product line. This collaboration aims to alleviate operator and maintenance burdens, enhance performance, and ensure sustained operation success. Thi...

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced the appointment of Syam Nair as its new Chief Product Officer (CPO), effective Monday, July 7, 2025. Nair succeeds Harv Bhela, who concluded his tenure in June following a successful chapter of product leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624871234/en/Syam Nair, Chief Product Officer at NetApp Nair is a former Salesforce and...

Members of the Ethereum community today announced the release of a new report targeting institutional investors that presents “The Bull Case for ETH.” The report, which can be found in full here, represents a collaborative effort between many prominent leaders and researchers from the Ethereum ecosystem, with contributors that include Etherealize co-founders Vivek Raman, Danny Ryan, and Grant Hummer, as well as Founder and CEO of ether.fi Mike Silagadze. The report outlines why ETH – the nati...

GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, officially launches the GD32C231 series, a high-performance entry-level microcontroller built on the Arm® Cortex®-M23 core. The GD32C231 new series expands GigaDevice’s MCU portfolio, offering cost-effective solutions for applications such as small home appliances, BMS (Battery Management Systems), small-screen display devices, handheld electronics, industrial ...

NIKE, Inc. (NYSE:NKE) today announced Jørgen Vig Knudstorp has been nominated for election to its Board of Directors at the Company’s 2025 annual meeting of shareholders, to be held on September 9, 2025. Mr. Knudstorp was President and Chief Executive Officer of the LEGO Group (“LEGO”) from 2004 to 2016, Executive Chair of LEGO Brand Group from 2017 to 2023 and currently serves as Deputy Chair of the LEGO Foundation. He previously held various leadership positions at LEGO from 2001 to 2004. ...

Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced the results of the 10th annual “State of Smart Manufacturing Report: Automotive Edition.” The global study encompasses the responses of 130 leaders across automotive and tire manufacturers, original equipment manufacturers, engineering procurement companies and systems integrators across 15 countries, revealing a sector rapidly embracin...

Andersen Consulting enters into a Collaboration Agreement with Sidat Hyder Morshed Associates (Sidat Hyder), a management consulting and technology services firm, strengthening its global capabilities and deepening its presence in an emerging market. Founded in 1986, Sidat Hyder provides an extensive range of services, including strategy and management consulting, HR consulting, recruitment and outsourcing, and financial consulting. The firm serves a diverse portfolio of clients across sector...

Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved ADCETRIS® (brentuximab vedotin) in combination with etoposide, cyclophosphamide, doxorubicin, dacarbazine and dexamethasone (ECADD) – a chemotherapy regimen – in adult patients with newly diagnosed Stage IIb with risk factors/III/IV Hodgkin lymphoma. The decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) on April 25, 2025. The appr...